主页 > 医学文档 >
【medical-news】研究发现新的可阻断细胞癌变的小
New molecules discovered that block cancer cells from modifying cell DNA
Medical Research News
Published: Sunday, 14-Oct-2007
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
The findings were presented at the Prostate Cancer Foundation's annual Scientific Retreat. Funding for the research was provided by the Prostate Cancer Foundation, as well as from the National Cancer Institute and the Avon Foundation.
Epigenetics refers to changes to genes other than changes to the DNA sequence itself, such as the addition of molecules to the DNA strand. While the development of cancer can arise from defective or mutated genes, it can also arise from these changes that can actually prevent a cell from acting as it should. Cancer cells exploit this process, putting some genes in "cold storage" or "turned off" by modifying the cell DNA in a process known as methylation.
Lead researcher William Nelson, M.D., Ph.D., Professor of Oncology and Urology at the Johns Hopkins Kimmel Cancer Center, explained the findings. "One of the proteins in the cell that triggers this process is called a methyl-CpG binding protein, or MBD. We have discovered an antagonist of MBD2 that keeps this protein from binding to methylated genes. If the protein can't bind to the gene, then it can't keep the gene 'turned off' and the gene is turned back on - able to act in the way it is supposed to."
Nelson noted that the discovery is particularly exciting because of previous research that shows the importance of being able to alter the methylation process in DNA. When mice were developed without the gene that permits this process, they don't develop cancer. When the gene is removed from cancer cells, they "turn on" genes again in appropriate ways. "The small molecules that we've discovered mimic this process, so they may be very exciting lead candidates for the next generation of drugs that may help restore gene function in prostate cancer," said Nelson.
"This entire field of exploration has been tantalizing for a decade," said Nelson, "but has only begun to deliver fruit in just the past couple of years. This mechanism of action permits us to look for much more targeted therapies for prostate cancer, and for other cancers as well, such as breast cancer."
The promise of this field is evident in the current pipeline of diagnostic and therapeutic products in development. There are diagnostic tests being tested that focus on detecting the methylated DNA, which would permit prostate cancer diagnosis at an earlier stage and in a more precise manner. There is also a first generation of FDA-approved medications that work to reverse the methylation process in cancer cells. They include azacitine (Vidaza) and decitabine (Dacogen), both for the treatment of myelodysplastic syndrome, diseases in which the production of blood cells by the bone marrow is disrupted. Vorinostat (Zolinza) also works to turn back on silenced genes, and is approved for use in cutaneous T cell lymphomas.
Dr. Nelson noted that the Prostate Cancer Foundation funding was essential for the research that resulted in this discovery. "PCF supported our research at a time when it was a very new idea. Their investment permitted us to make critical discoveries that have not only put us along the pathway this field -- hopefully one day resulting in new drugs -- but that also allowed us to secure competitive research funding from the National Cancer Institute," explained Nelson 本人已认领该文编译，48小时后若未提交译文，请其他战友自由认领。 粗稿：
New molecules discovered that block cancer cells from modifying cell DNA
Medical Research News
Published: Sunday, 14-Oct-2007
研究发现新的可阻断癌细胞修改细胞DNA的分子 编译稿(980字)：
研究发现新的可阻断癌细胞修改细胞DNA的分子
研究人员发现了新的小分子，这些小分子可能在前列腺癌细胞将正常细胞转变为癌细胞过程中阻断癌细胞关闭正常基因的表达。实验胚胎学领域的这一重大发现预示着将会产生新的诊断检测手段及治疗癌症的药物疗法。该发现是在前列腺癌基金会的科学年会上发布的。本研究受到前列腺癌基金会、国立癌症研究所及Avon基金会的资助。
实验胚胎学涉及的内容不是DNA序列本身的变化，而是基因的改变，如向DNA链添加分子。发生缺陷或突变的基因能够诱发癌症，那么同理，阻止基因发生这种变化就可阻断癌症的发生。癌细胞正是利用这一过程来发挥作用，即通过甲基化作用修饰细胞DNA，从而将一些基因打入“冷宫”或关闭基因的表达。
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-06-16 05:11
医学,生命科学网